Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
Aaron Philip Mitchell, Akriti Mishra Meza, Katherine S. Panageas, Allison Lipitz‐Snyderman, Azeez Farooki, Michael J. Morris
Topics & Concepts
MedicineDenosumabProstate cancerBone metastasisZoledronic acidAndrogen deprivation therapyOncologyInternal medicineMetastasisSurgeryCancerOsteoporosisBone health and treatmentsProstate Cancer Treatment and ResearchManagement of metastatic bone disease